The new collaboration is seeking to develop a ‘microbiome’ drug for multiple sclerosis and rheumatoid arthritis.
Author’s archive
The method is aimed at those under 50 with hereditary high colorectal risk.
The company is developing tech to greatly boost accuracy of common flu and malaria tests.
Earmarks $1.27 million for 2018 as initiative marks Discovery Square groundbreaking.
Apollo Endosurgery is touting an alternative to unpopular bariatric procedures.
Masonic Cancer Center’s Chen and Tocagen Inc. announce ‘impressive’ results.
Collaboration with United Therapeutics could include opening a similar facility in Rochester later on.
Medibio Ltd. also wrapped a nearly $14 million funding round this week.
Two parties file patent application for unique self-centering catheter guide.
The latest investment came from Southern Minnesota Initiative Foundation philanthropists.
Second early-stage trial of ‘remyelinating’ drug candidate is close to completion.
The Center for Drug Design research team is readying "Sulfanegen" for clinical trials.
New collaboration is clinic’s second in emerging personalized wellness field.
U of M spinoff has tech to analyze microbial communities for health, ag clients.
Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.
‘Minnesota Partnership’ seeks to develop pipeline of biotech startups, job creation.
Recent U of M study shows 7.2 percent of rural hospitals have closed OB units.
Driven to Discover building is a step up in recruiting for on-site studies.